Coffee and cigarette use: Association with suicidal acts in 352 Sardinian bipolar disorder patients

Bipolar Disorders

Volumn 11, Issue 5, 2009, Pages 494-503

  Baethge, Christopher ^a   Tondo, Leonardo ^b,c,d   Lepri, Beatrice ^c,d   Baldessarini, Ross J ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d Lucio Bini Mood Disorders Research Center   (Italy)

Author keywords

Alcohol; Bipolar disorders; Caffeine; Nicotine; Substance abuse; Suicidal behavior

Indexed keywords

CAFFEINE; NICOTINE;

ADULT; ARTICLE; ATTRIBUTABLE RISK; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; HIGH RISK BEHAVIOR; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; SMOKING HABIT; SUICIDAL BEHAVIOR;

ADULT; BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; COFFEE; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SUICIDE, ATTEMPTED;

EID: 67749093310     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00727.x     Document Type: Article

References (67)

1. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiological Catchment Area (ECA) Study. JAMA 1990; 264: 2511-2518.
2. Chengappa KN, Levine J, Gershon S, Kupfer DJ. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I or II disorders in a voluntary registry. Bipolar Disord 2000; 2: 191-195.
3. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001; 3: 181-188.
4. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998; 50: 143-151.
5. Tondo L, Baldessarini RJ, Hennen J et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry 1999; 60 (Suppl. 2): 63-69.
6. Vieta E, Colom F, Martinez-Arán A, Benabarre A, Reinares M, Gasto C. Bipolar II disorder and comorbidity. Compr Psychiatry 2000; 41: 339-343.
7. Minnai GP, Tondo L, Salis P et al. Secular trends in first hospitalizations for major affective disorders with comorbid substance use. Int J Neuropsychopharmacol 2006; 9: 319-326.
8. Baethge C, Baldessarini RJ, Khalsa HM, Hennen J, Salvatore P, Tohen M. Substance abuse in first-episode bipolar I disorder: Indications for early intervention. Am J Psychiatry 2005; 162: 1008-1010.
9. Goldstein BI, Herrmann N, Shulman KI. Comorbidity in bipolar disorder among the elderly: Results from an epidemiological community sample. Am J Psychiatry 2006; 163: 319-321.
10. Tohen M, Greenfield SF, Weiss RD, Zarate CA Jr, Vagge LM. Effect of comorbid substance use disorders on the course of bipolar disorder: A review. Harv Rev Psychiatry 1998; 6: 133-141.
11. Strakowski SM, DelBello MP, Fleck DE, Arndt S. Impact of substance use on the course of bipolar disorder. Biol Psychiatry 2000; 48: 477-485.
12. Strakowski SM, DelBello MP, Fleck DE et al. Effects of co-occurring alcohol use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry 2005; 62: 851-858.
13. Strakowski SM, DelBello MP, Fleck DE et al. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry 2007; 64: 57-64.
14. Tondo L, Isacsson G, Baldessarini RJ. Suicide in bipolar disorder: Risk and prevention. CNS Drugs 2003; 17: 491-511.
15. Weiss RD, Griffin ML, Kolodziej ME et al. A randomized trial of integrated group therapy vs. group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 2007; 164: 100-107.
16. Baethge C, Hennen J, Khalsa HM, Salvatore P, Tohen M, Baldessarini RJ. Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord 2008; 10: 738-741.
17. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry 2004; 61: 1107-1115.
18. Ostacher MJ, Nierenberg AA, Perlis RH et al. Relationship between smoking and course of illness in bipolar disorder. J Clin Psychiatry 2006; 67: 1907-1911.
19. Derenne JL, Baldessarini RJ. Clozapine toxicity associated with smoking cessation: Case report. Am J Ther 2005; 12: 469-471.
20. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm 2007; 64: 1917-1921.
21. Newcomer JW. Metabolic syndrome and mental illness. Am J Manag Care 2007; 13 (Suppl. 7): S170-S177.
22. Bhuvaneswar C, Alpert J, Harsh V, Baldessarini RJ Adverse endocrine and metabolic effects of psychotropic drugs. CNS Drugs 2009; in press.
23. Brice CF, Smith AP. Effects of caffeine on mood and performance: Study of realistic consumption. Psychopharmacology 2002; 164: 188-192.
24. Tondo L, Rudas N. The course of a seasonal bipolar disorder influenced by caffeine. J Affect Disord 1991; 22: 249-251.
25. Kellner CH, Bachman DL. Olfactory hallucination after intravenous caffeine. Am J Psychiatry 1992; 149: 422-423.
26. Machado-Vieira R, Viale CI, Kapczinski F. Mania associated with an energy drink: Possible role of caffeine, taurine, and inositol. Can J Psychiatry 2001; 46: 454-455.
27. Baethge C. Grief Hallucinations: True or pseudo? Serious or not? An inquiry into psychopathological and clinical features of a common phenomenon. Psychopathology 2002; 35: 296-302.
28. Ogawa N, Ueki H. Secondary mania caused by caffeine. Gen Hosp Psychiatry 2003; 25: 136-144.
29. Leibenluft E, Fiero PL, Bartko JJ, Moul DE, Rosenthal NE. Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients. Am J Psychiatry 1993; 150: 294-301.
30. Jefferson JW. Lithium tremor and caffeine intake: Two cases of drinking less and shaking more. J Clin Psychiatry 1988; 4: 72-73.
31. Mester R, Toren P, Mizrachi I, Wolmer L, Karni N, Weizman A. Caffeine withdrawal increases lithium blood levels. Biol Psychiatry 1995; 37: 348-350.
32. Schou M, Kampf D. Lithium and the kidneys. In: Bauer M, Grof P, Müller-Oerlinghausen B eds. Lithium in Neuropsychiatry: The Comprehensive Guide. London: Informa-UK, 2006: 251-258.
33. Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000; 39: 127-153.
34. de Leon J. Atypical antipsychotic dosing: The effect of smoking and caffeine. Psychiatr Serv 2004; 55: 491-493.
35. Broderick PJ, Benjamin AB, Dennis LW. Caffeine and psychiatric medication interactions: A review. J Okla State Med Assoc 2005; 98: 380-384.
36. Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol 1993; 3: 375-381.
37. Kawachi I, Willet WC, Colditz GA, Stampfer MJ, Speizer FE. A prospective study of coffee drinking and suicide in women. Arch Int Med 1996; 156: 521-525.
38. Tanskanen A, Tuomilehto J, Viinimäki H, Vartiainen E, Lehtonen J, Puska P. Heavy coffee drinking and risk of suicide. Eur J Epidemiol 2000; 16: 789-791.
39. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 2001; 178 (Suppl. 41): S184-S190.
40. Tondo L, Lepri B, Baldessarini RJ. Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr Scand 2007; 116: 419-428.
41. Baldessarini RJ, Hennen J. Genetics of suicide: An overview. Harv Rev Psychiatry 2004; 12: 1-13.
42. McElroy SL, Frye MA, Suppes T et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002; 63: 207-213.
43. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: meta-analysis. Br J Psychiatry 1997; 170: 205-228.
44. Hawton K, Sutton L, Haw C, Sinclair J, Harriss L. Suicide and attempted suicide in bipolar disorder: A systematic review of risk factors. J Clin Psychiatry 2005; 66: 693-704.
45. Valtonen H, Suominen K, Mantere O, Leppämäki S, Avrilommi P, IsometsäEK. Suicidal ideation and attempts in bipolar I and II disorders. J Clin Psychiatry 2005; 66: 1456-1462.
46. Marangell LB, Bauer MS, Dennehy EB et al. Prospective predictors of suicide and suicide attempts in 1556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord 2006; 8: 556-575.
47. Oquendo MA, Currier D, Mann JJ. Prospective studies of suicidal behavior in major depressive and bipolar disorders: What is the evidence for predictive factors? Acta Psychiatr Scand 2006; 114: 151-158.
48. Oquendo MA, Galfalvy H, Russo S et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 2004; 161: 1433-1441.
49. McGirr A, Turecki G. The relationship of impulsive aggressiveness to suicidality and other depression linked behaviours. Curr Psychiatry Rep 2007; 9: 460-466.
50. Brodsky BS, Mann JJ, Stanley B et al. Familial transmission of suicidal behavior: Factors mediating the relationship between childhood abuse and offspring suicide attempts. J Clin Psychiatry 2008; 69: 584-596.
51. Childs E, de Wit H. Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology 2006; 185: 514-523.
52. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after double-blind cessation of caffeine consumption. N Engl J Med 1992; 327: 1109-1114.
53. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. Am J Psychiatry 2005; 162: 1805-1819.
54. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disord 2006; 8: 625-639.
55. Carson SW, Gagnon A, Banhai YD. Pharmacokinetic and pharmacodynamic effects of caffeine on lithium disposition in normal volunteers. Pharmacotherapy 1989; 9: 196-197.
56. Istituto nazionale di statistica. Regional data-set on health. http://www.istat.it/sanita/sociosan/english.html. Last accessed May 20, 2009.
57. Tanskanen A, Viinamäki H, Hintikka J, Koivumaa-Honkanen HT, Lehtonen J. Smoking and suicidality among psychiatric patients. Am J Psychiatry 1998; 155: 129-130.
58. Slama F, Bellivier F, Henry C et al. Bipolar patients with suicidal behavior: Toward the identification of a clinical subgroup. J Clin Psychiatry 2004; 65: 1035-1039.
59. Oquendo MA, Bongiovi-Garcia ME, Galfalvy H et al. Sex differences in clinical predictors of suicidal acts after major depression: A prospective study. Am J Psychiatry 2007; 164: 134-141.
60. Rihmer Z, Döme P, Gonda X et al. Cigarette smoking and suicide attempts in psychiatric outpatients in Hungary. Neuropsychopharmacol Hung 2007; 9: 63-67.
61. Beratis S, Lekka NP, Gabriel J. Smoking among suicide attempters. Compr Psychiatry 1997; 38: 74-79.
62. Hemenway D, Solnick SJ, Colditz GA. Smoking and suicide among nurses. Am J Public Health 1993; 83: 249-251.
63. Miller M, Hemenway D, Rimm E. Cigarettes and suicide: A prospective study of 50,000 men. Am J Public Health 2000; 90: 768-773.
64. Grunebaum MF, Ramsay SR, Galfalvy HC et al. Correlates of suicide attempt history in bipolar disorder: A stress-diathesis perspective. Bipolar Disord 2006; 8: 551-557.
65. Malone KM, Waternaux C, Haas GL, Cooper TB, Li S, Mann JJ. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorder. Am J Psychiatry 2003; 160: 773-779.
66. Westfall TC, Westfall DP. Neurotransmission: The autonomic and somatic motor systems. In: Brunton LL, Lazo JS, Parker KL eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 2005: 183-199.
67. O'Brien CP. Drug addiction and drug abuse. In: Brunton LL, Lazo JS, Parker KL eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 2005: 607-627.